Balicatib

DB12239InvestigationalSmall molecule

Balicatib has been used in trials studying the treatment of Osteoporosis and Knee Osteoarthritis.

Chemical structure of Balicatib
Mechanism
Curator reviewed
Formula / weight
C23H33N5O2 · 411.55 g/mol (avg)
Code names
AAE-581

Resolves to

Compound
UNIIE00MVC7O57CAS354813-19-7ChEMBLCHEMBL371064PubChem10201696
Structure
InChIKeyLLCRBOWRJOUJAE-UHFFFAOYSA-NSMILESCCCN1CCN(CC1)C1=CC=C(C=C1)C(=O)NC1(CCCCC1)C(=O)NCC#N
Targets
P43235CTSK

What you can answer from here — as of August 26, 2024

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Balicatib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In